Carlyle Group Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001527166

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q1 2024 · 32 positions · Total reported value $1.59B · Top-10 concentration 93.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 21.1% · 0 new · 1 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.3% · vs SPY -18.4% · Prev Value $10.00B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.8% · vs SPY -6.0% · Latest Value $8.36B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, Carlyle Group Inc. disclosed 32 equity positions with a combined reported value of $1.59B. The filing implies a focused portfolio: its ten largest positions account for 93.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were QDEL ($597.34M), GTM ($420.70M), SLNO ($173.12M). By sector, the heaviest allocations are Health Care 43.8%, Technology 28.4%. Versus the prior quarter, allocation shifted toward Other (+7.5pp) and away from Health Care (-4.0pp), Technology (-4.8pp).

Versus the prior quarter, Carlyle Group Inc. opened 0 new positions, trimmed 1 and fully exited 3, a turnover rate of 21.1% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q1 2024 were QTTB ($18.07M), DNUT ($5.19M), NABL ($1.23M).

Of the 3 positions fully exited versus the prior quarter, the largest were VERA ($22.10M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • QTTB Q32 Bio Inc. · $18.07M
  • DNUT KRISPY KREME INC · $5.19M
  • NABL N-ABLE INC · $1.23M
  • SWI SOLARWINDS CORP · $1.18M
  • AVGO BROADCOM INC · $1.00M
  • NU NU HLDGS LTD · $863.03K
  • DASH DOORDASH INC · $572.36K
  • CFLT CONFLUENT INC · $234.49K

Fully Exited (vs previous quarter)

  • VERA VERA THERAPEUTICS INC · prev qtr: $22.10M

Insider Transactions (Form 4)

Latest Carlyle Group Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

The Carlyle Group was founded in 1987 in Washington, DC by Bill Conway, Dan D'Aniello and David Rubenstein and is one of the largest alternative asset managers in the world. It listed on Nasdaq (CG) in 2012.

Firm Snapshot

It runs three segments: Global Private Equity, Global Credit and Carlyle AlpInvest, its private-funds and secondaries solutions business. The firm describes its model as connecting people, ideas and capital across one network.

Harvey Schwartz has been CEO since 2023.

  • Headquarters: WASHINGTON, DC, United States
  • SEC registration: 801-52462 (status: Approved), registered 1996-08-06
  • Regulatory AUM (Form ADV): $200.75B as of 2026-07-07
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 314 private funds, of which 1 hedge funds

Portfolio Structure

  • 16 positions · $8.36B reported value (Q3 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: MDLN (MEDLINE INC) at 77.6%
  • Average position size: $522.59M

Sector Tilt

  • Health Care 78.0%
  • Industrials 21.6%
  • Information Technology 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 2 added, 1 reduced, 3 exited
  • 13 positions unchanged

Reading the 13F

The 13F is a rounding error at Carlyle: most assets are unlisted company equity, private credit and fund interests that 13F never captures. What appears here — listed vehicles and CLO-related holdings — is a side sleeve.

The firm background and strategy notes are written by HoldingsHub editors from public sources; holdings, trading and Form ADV figures come from the firm's public SEC filings. Not investment advice.

Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 12.46M $597.34M 37.66%
37.66%
Hold
2 26.24M $420.70M 26.52%
26.52%
Reduce
3 4.07M $173.12M 10.91%
10.91%
Add
4 6.25M $94.01M 5.93%
5.93%
Hold
5 2.46M $39.44M 2.49%
2.49%
Hold
6 9.21M $38.23M 2.41%
2.41%
Reduce
7 3.50M $37.10M 2.34%
2.34%
Hold
8 1.07M $31.30M 1.97%
1.97%
Reduce
9 1.84M $30.50M 1.92%
1.92%
Hold
10 4.07M $27.08M 1.71%
1.71%
Hold
11 1.31M $18.32M 1.16%
1.16%
Hold
12 1.10M $18.07M 1.14%
1.14%
New
13 477.50K $17.00M 1.07%
1.07%
Hold
14 220.50K $9.97M 0.63%
0.63%
Hold
15 2.95M $6.90M 0.43%
0.43%
Add
16 340.75K $5.19M 0.33%
0.33%
New
17 2.70M $4.45M 0.28%
0.28%
Hold
18 4.81M $3.16M 0.20%
0.20%
Hold
19 192.88K $2.72M 0.17%
0.17%
Reduce
20 4.94M $2.72M 0.17%
0.17%
Add
21 2.90M $2.28M 0.14%
0.14%
Hold
22 93.73K $1.23M 0.08%
0.08%
New
23 93.73K $1.18M 0.07%
0.07%
New
24 755 $1.00M 0.06%
0.06%
New
25 72.34K $863.03K 0.05%
0.05%
New
26 3.33M $845.33K 0.05%
0.05%
Hold
27 4.16K $572.36K 0.04%
0.04%
New
28 9.62K $364.79K 0.02%
0.02%
Hold
29 314.40K $240.61K 0.01%
0.01%
Hold
30 7.68K $234.49K 0.01%
0.01%
New
31 281.64K $160.53K 0.01%
0.01%
Hold
32 13.33K $28.67K 0.00%
0.00%
Hold

FAQ

What did Carlyle Group Inc. buy in 2024-Q1?

In its 2024-Q1 13F filing, Carlyle Group Inc. reported 32 equity positions worth $1.59B in aggregate; its largest disclosed positions were QDEL ($597.34M), GTM ($420.70M), SLNO ($173.12M).

How large is Carlyle Group Inc.'s portfolio?

Carlyle Group Inc. reported $1.59B of long equity holdings across 32 positions as of 2024-Q1. Top-10 holdings account for 93.9% of reported value.

What is Carlyle Group Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/carlyle/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →